Does SECUKINUMAB Cause Metastases to bone? 37 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Metastases to bone have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
37
Reports of Metastases to bone with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
13
Deaths
25
Hospitalizations
How Dangerous Is Metastases to bone From SECUKINUMAB?
Of the 37 reports, 13 (35.1%) resulted in death, 25 (67.6%) required hospitalization, and 6 (16.2%) were considered life-threatening.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which SECUKINUMAB Alternatives Have Lower Metastases to bone Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG